Additional studies in progress suggest that ARV-825 may also be effective in boosting the response to estrogen deprivation (aromatase inhibition), another ingredient of normal of care in ER+ breast cancer. Feasible new methods for that prognosis and treatment of AML. (A) The identification of Tre